News and Events 
Press Releases
06.06.2007
FierceBiotech Names Syndax Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2007
04.13.2007
Syndax Pharmaceuticals Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
04.03.2007
Syndax Pharmaceuticals Inc. closes $40 Million Series A Financing
Events
02.12.2008
Joanna Horobin, MD, speaks at the 10th Annual BioCEO & Investor Conference 2008
